Salivary duct carcinoma—A clinicopathologic study of 12 cases
✍ Scribed by Afzelius, Lars-Erik ;Cameron, W. Robert ;Svensson, Christer
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1987
- Weight
- 480 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0148-6403
No coin nor oath required. For personal study only.
✦ Synopsis
Salivary duct carcinoma (SDC), a recently defined malignant tumor usually of major salivary glands, has probably been included in the group of adenocarcinomas, NOS. As yet, only a few descriptions of its clinical behavior have appeared. We have found 12 cases of SDC treated at our institution since 1970 and have reviewed their presentation and course. Despite total parotidectomy in most cases and radiotherapy in all, most patients have succumbed to their tumors, six with distant metastases. SDC appears to be a highly malignant tumor requiring aggressive combined therapy for locoregional control. The high incidence of systemic spread indicates a need for effective chemotherapy on an adjuvant basis.
📜 SIMILAR VOLUMES
BACKGROUND. Salivary duct carcinoma (SDC) is a high grade aggressive malignancy of the major salivary glands. Clinical and pathologic features that may be predictive of survival are not well delineated. The microscopic features of SDC are remarkably similar to those of mammary ductal carcinoma, rais
Nelson's syndrome), seven had prolactin-producing tumors, and one had a nonfunctioning tumor. No evidence of diabetes insipidus was seen in any case. Four-1 Departments of Laboratory Medicine and Pateen tumors were initially considered macroadenomas. Of the ten cases for whom thology, Mayo Clinic an
## BACKGROUND. Malignant myoepithelioma (MME) of the salivary gland, also known as myoepithelial carcinoma, is rare and its biologic behavior has not been clarified fully. ## METHODS. Ten cases of MME were analyzed for their clinicopathologic features and immunohistochemical characteristics, focu